Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan: fortebiorx.com (FBRX)

Forte Biosciences Inc - logo grafis emiten FBRX

Forte Biosciences, Inc. (FBRX) is implementing robotic antibody screening to accelerate the development of therapies for rare skin pathologies. The quarterly EPS growth rate reflects capital dynamics, with the value holding at -2.40. The development strategy is based on the diversification of topical drugs to minimize risks. Competent management led by Paul Wagner is persistently protecting assets while ensuring the search for new growth vectors.

Forte Biosciences (FBRX) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan saka 04.07.2022 nganti 06.09.2026

Forte Biosciences (FBRX) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
Pambiji fundamental perusahaan:fortebiorx.com - FBRX
Produk asil prodhuksi fortebiorx.com

Earnings per share dynamics determine the investment stability of the issuer through the monitoring of cash flows. This metric measures the percentage change in net income for the quarter relative to the previous period. Recorded quarterly EPS growth allows for the identification of capital contraction phases and liquidity risks. For Forte Biosciences, Inc. (FBRX), negative values are expected, as the company is investing in the clinical validation of autoimmune disease therapies. The current pipeline confirms the strategic objective of the business.

Analisis perusahaan pesaing

KRYS: Wutah bathi EPS kuartalan|APGE - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Arcutis Biotherapeutics, Inc.|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan VCEL (Vericel)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Oruka Pharma (ORKA)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Sanara MedTech|Wutah bathi EPS kuartalan DBVT (DBV Technologies SA)|Solesence Inc (SLSN) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|DERM: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan EMPG|SLGL (sol-gel.com) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|AXIL (AXIL Brands, Inc.) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|MDCX (Medicus Pharma Corp) - Wutah bathi EPS kuartalan|Verrica Pharmaceuticals (VRCA) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HOTH (Hoth Therapeutics, Inc.)|BFRI - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan VYNE (VYNE Therapeutics)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan SNOA|Quoin Pharmaceuticals Ltd. - Wutah bathi EPS kuartalan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Azitra Corporation AZTR|DRMA (Dermata) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Elevai Labs Inc. (ELAB) - Wutah bathi EPS kuartalan|RVNC (Revance Therapeutics, Inc.) - Wutah bathi EPS kuartalan